Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Davignon, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 124 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Grewal, T; Priceputu, E; Davignon, J; Bernier, L
      Identification of a gamma-interferon-responsive element in the promoter ofthe human macrophage scavenger receptor A gene

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    2. Ramassamy, C; Krzywkowski, P; Averill, D; Lussier-Cacan, S; Theroux, L; Christen, Y; Davignon, J; Poirier, J
      Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain

      MOLECULAR BRAIN RESEARCH
    3. Marcoux, C; Tremblay, M; Fredenrich, A; Davignon, J; Cohn, JS
      Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins

      METABOLISM-CLINICAL AND EXPERIMENTAL
    4. Krimbou, L; Marcil, M; Davignon, J; Genest, J
      Interaction of lecithin : cholesterol acyltransferase (LCAT)center dot alpha(2)-macroglobulin complex with low density lipoprotein receptor-related protein (LRP) - Evidence for an alpha(2)-macroglobulin/LRP receptor-mediatedsystem participating in LCAT clearance

      JOURNAL OF BIOLOGICAL CHEMISTRY
    5. Insull, W; Koren, M; Davignon, J; Sprecher, D; Schrott, H; Keilson, LM; Brown, AS; Dujovne, CA; Davidson, MH; McLain, R; Heinonen, T
      Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia

      ATHEROSCLEROSIS
    6. Davignon, J; Mabile, L
      Mechanisms of action of statins and their pleiotropic effects

      ANNALES D ENDOCRINOLOGIE
    7. Mabile, L; Piolot, A; Boulet, L; Fortin, LJ; Doyle, N; Rodriguez, C; Davignon, J; Blache, D; Lussier-Cacan, S
      Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    8. Bourdon, E; Loreau, N; Davignon, J; Bernier, L; Blache, D
      Involvement of oxysterols and lysophosphatidylcholine in the oxidized LDL-induced impairment of serum albumin synthesis by HEPG2 cells

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    9. Ramassamy, C; Averill, D; Beffert, U; Theroux, L; Lussier-Cacan, S; Cohn, JS; Christen, Y; Schoofs, A; Davignon, J; Poirier, J
      Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain

      NEUROBIOLOGY OF DISEASE
    10. Genest, J; Nguyen, NH; Theroux, P; Davignon, J; Cohn, JS
      Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    11. Marcoux, C; Hopkins, PN; Wang, T; Leary, ET; Nakajima, K; Davignon, J; Cohn, JS
      Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state

      JOURNAL OF LIPID RESEARCH
    12. Batal, R; Tremblay, M; Barrett, PHR; Jacques, H; Fredenrich, A; Mamer, O; Davignon, J; Cohn, JS
      Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

      JOURNAL OF LIPID RESEARCH
    13. Carmena, R; Roy, M; Roederer, G; Minnich, A; Davignon, J
      Coexisting dysbetalipoproteinemia and familial hypercholesterolemia - Clinical and laboratory observations

      ATHEROSCLEROSIS
    14. Cohn, JS; Marcoux, C; Davignon, J
      Detection, quantification, and characterization of potentially atherogenictriglyceride-rich remnant lipoproteins

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    15. Davignon, J; Laaksonen, R
      Low-density lipoprotein-independent effects of statins

      CURRENT OPINION IN LIPIDOLOGY
    16. Ramassamy, C; Averill, D; Beffert, U; Bastianetto, S; Theroux, L; Lussier-Cacan, S; Cohn, JS; Christen, Y; Davignon, J; Quirion, R; Poirier, J
      Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype

      FREE RADICAL BIOLOGY AND MEDICINE
    17. Gesquiere, L; Loreau, N; Minnich, A; Davignon, J; Blache, D
      Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells

      FREE RADICAL BIOLOGY AND MEDICINE
    18. Beffert, U; Aumont, N; Dea, D; Lussier-Cacan, S; Davignon, J; Poirier, J
      Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures

      MOLECULAR BRAIN RESEARCH
    19. Marcoux, C; Tremblay, M; Nakajima, K; Davignon, J; Cohn, JS
      Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients

      JOURNAL OF LIPID RESEARCH
    20. Davignon, J; Cohn, JS; Mabile, L; Bernier, L
      Apolipoprotein E and atherosclerosis: insight from animal and human studies

      CLINICA CHIMICA ACTA
    21. Beffert, U; Cohn, JS; Petit-Turcotte, C; Tremblay, M; Aumont, N; Ramassamy, C; Davignon, J; Poirier, J
      Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoproteinE genotype dependent

      BRAIN RESEARCH
    22. Lussier-Cacan, S; Xhignesse, M; Kessling, AM; Davignon, J; Sing, CF
      Sources of variation in plasma lipid and lipoprotein traits in a sample selected for health

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    23. BATAL R; TREMBLAY M; KRIMBOU L; MAMER O; DAVIGNON J; GENEST J; COHN JS
      FAMILIAL HDL DEFICIENCY CHARACTERIZED BY HYPERCATABOLISM OF MATURE APOA-I BUT NOT PROAPOA-I

      Arteriosclerosis, thrombosis, and vascular biology
    24. DAVIGNON J; GENEST J
      GENETICS OF LIPOPROTEIN DISORDERS

      Endocrinology and metabolism clinics of North America
    25. MINNICH A; BALOUKAS J; ROEDERER G; LUSSIERCACAN S; DAVIGNON J; GENEST J
      LIPOPROTEIN-LIPASE GENE-MUTATIONS IN CORONARY-ARTERY DISEASE

      Canadian journal of cardiology
    26. DAVIGNON J; PEARSON TA
      BEYOND LDL-CHOLESTEROL - CAN FURTHER REDUCTIONS IN CAD RISK BE ACHIEVED BY CONSIDERING TRIGLYCERIDES

      Canadian journal of cardiology
    27. DAVIGNON J
      ADVANCES IN DRUG-TREATMENT OF DYSLIPIDEMIA - FOCUS ON ATORVASTATIN

      Canadian journal of cardiology
    28. WESOLOWSKA E; MARCIL M; LUSSIERCACAN S; DAVIGNON J; LATOUR Y; GENEST J
      ANGIOTENSIN-CONVERTING ENZYME INSERTION DELETION POLYMORPHISM IN FRENCH-CANADIAN SUBJECTS WITH PREMATURE CORONARY-ARTERY DISEASE/

      Pathologie et biologie
    29. FARLOW MR; LAHIRI DK; POIRIER J; DAVIGNON J; SCHNEIDER L; HUI SL
      TREATMENT OUTCOME OF TACRINE THERAPY DEPENDS ON APOLIPOPROTEIN GENOTYPE AND GENDER OF THE SUBJECTS WITH ALZHEIMERS-DISEASE

      Neurology
    30. BEFFERT U; AUMONT N; DEA D; LUSSIERCACAN S; DAVIGNON J; POIRIER J
      BETA-AMYLOID PEPTIDES INCREASE THE BINDING AND INTERNALIZATION OF APOLIPOPROTEIN-E TO HIPPOCAMPAL-NEURONS

      Journal of neurochemistry
    31. KRIMBOU L; TREMBLAY M; JACQUES H; DAVIGNON J; COHN JS
      IN-VITRO FACTORS AFFECTING THE CONCENTRATION OF GAMMA-LPE (GAMMA-LPE)IN HUMAN PLASMA

      Journal of lipid research
    32. Krimbou, L; Tremblay, M; Davignon, J; Cohn, JS
      Association of apolipoprotein E with alpha(2)-macroglobulin in human plasma

      JOURNAL OF LIPID RESEARCH
    33. MARCOUX C; TREMBLAY M; FREDENRICH A; JACQUES H; KRIMBOU L; NAKAJIMA K; DAVIGNON J; COHN JS
      PLASMA REMNANT-LIKE PARTICLE LIPID AND APOLIPOPROTEIN LEVELS IN NORMOLIPIDEMIC AND HYPERLIPIDEMIC SUBJECTS

      Atherosclerosis (Amsterdam)
    34. GREWAL T; BOUDREAU M; ROY M; CHAMBERLAND A; LEFEBVRE C; LAVIGNE J; DAVIGNON J; MINNICH A
      EXPRESSION OF GAMMA-IFN RESPONSIVE GENES IN SCAVENGER RECEPTOR OVER-EXPRESSING MONOCYTES IS ASSOCIATED WITH XANTHOMATOSIS

      Atherosclerosis (Amsterdam)
    35. BERNIER L; ROY M; DUFOUR R; DAVIGNON J
      PREVALENCE OF FRENCH-CANADIAN MUTATIONS OF THE LDL-RECEPTOR AND LIPOPROTEIN-LIPASE GENES IN FAMILIES OF FAMILIAL COMBINED HYPERLIPIDEMIA

      Atherosclerosis (Amsterdam)
    36. GENEST J; THEROUX P; DAVIGNON J; COHN JS
      EFFECT OF MICRONIZED FENOFIBRATE ON PLASMA-LIPOPROTEIN LEVELS AND HEMOSTATIC PARAMETERS IN THE FED AND FASTED STATE

      Circulation
    37. MARCOUX C; TREMBLAY M; FREDENRICH A; NAKAJIMA K; DAVIGNON J; COHN JS
      REMNANT-LIKE PARTICLES ARE ENRICHED IN APOC-III IN PATIENTS WITH FASTING HYPERTRIGLYCERIDEMIA AND FURTHER ENRICHED IN APOC-III IN HYPERTRIGLYCERIDEMIC PATIENTS FED A FAT-RICH MEAL

      Circulation
    38. FARNIER M; DAVIGNON J
      CURRENT AND FUTURE TREATMENT OF HYPERLIPIDEMIA - THE ROLE OF STATINS

      The American journal of cardiology
    39. DAVIGNON J; HANEFELD M; NAKAYA N; HUNNINGHAKE DB; INSULL W; OSE L
      CLINICAL EFFICACY AND SAFETY OF CERIVASTATIN - SUMMARY OF PIVOTAL PHASE IIB III STUDIES/

      The American journal of cardiology
    40. DAVIGNON J
      METHODS AND END-POINT ISSUES IN CLINICAL DEVELOPMENT OF LIPID-ACTING AGENTS WITH PLEIOTROPIC EFFECTS

      The American journal of cardiology
    41. FRUCHART JC; BREWER B; LEITERSDORF E; BROCHIER M; BROWN G; CALVO C; CARMENA R; CESKA R; LOYSOONG WC; DAVIGNON J; GOTTO A; GRUNDY S; HAMSTEN A; KEECH A; MATSUZAWA Y; PATCH JR; PAOLETTI R; RASLOVA K; SMIRNOV V; STEINER G; THOMPSON G; ZHU JR
      CONSENSUS FOR THE USE OF FIBRATES IN THE TREATMENT OF DYSLIPOPROTEINEMIA AND CORONARY HEART-DISEASE

      The American journal of cardiology
    42. OOI TC; HEINONEN T; ALAUPOVIC P; DAVIGNON J; LEITER L; LUPIEN PJ; SNIDERMAN AD; TAN MH; TREMBLAY G; SORISKY A; SHURZINSKE L; BLACK DM
      EFFICACY AND SAFETY OF A NEW HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITOR, ATORVASTATIN, IN PATIENTS WITH COMBINED HYPERLIPIDEMIA -COMPARISON WITH FENOFIBRATE

      Arteriosclerosis, thrombosis, and vascular biology
    43. COHN JS; GIROUX LM; FORTIN LJ; DAVIGNON J
      PREVALENCE OF DOUBLE PRE-BETA LIPOPROTEINEMIA IN HYPERLIPIDEMIC PATIENTS IS INFLUENCED BY GENDER, MENOPAUSAL STATUS, AND APOE PHENOTYPE

      Arteriosclerosis, thrombosis, and vascular biology
    44. LEVY E; MINNICH A; CACAN SL; THIBAULT L; GIROUX LM; DAVIGNON J; LAMBERT M
      ASSOCIATION OF AN EXON-3 MUTATION (TRP66-]GLY) OF THE LDL RECEPTOR WITH VARIABLE EXPRESSION OF FAMILIAL HYPERCHOLESTEROLEMIA IN A FRENCH-CANADIAN FAMILY

      Biochemical and molecular medicine
    45. WEBER M; MCNICOLL S; MARCIL M; CONNELLY P; LUSSIERCACAN S; DAVIGNON J; LATOUR Y; GENEST J
      METABOLIC FACTORS CLUSTERING, LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN-B, LIPOPROTEIN (A) AND APOLIPOPROTEIN-E PHENOTYPES IN PREMATURE CORONARY-ARTERY DISEASE IN FRENCH-CANADIANS

      Canadian journal of cardiology
    46. GENEST J; WEBER M; MCNICOLL S; LUSSIERCACAN S; DAVIGNON J; LATOUR Y
      METABOLIC AISLE FACTOR CLUSTERING IN PREMATURE CORONARY-ARTERY DISEASE IN FRENCH-CANADIANS

      Journal of the American College of Cardiology
    47. ZUCK P; RIO Y; TRINH A; DELAVAULT P; PETITFRERE I; CLAUDE JL; CROCE C; CAUBEL F; DOVAN R; GROSSIER JM; HENLE D; KOCH C; MULLER D; PERREIN C; PIERRON J; PRIME T; RICHTER D; ROSZAK E; MONIEZ D; DOURNOVO P; MONTEAU N; CAVALIER B; ALLEGRINI C; GRIMALDI JF; GUERIN P; GUIRAUD JP; PUGET A; LEONARDELLI M; ALFIERISIADOUS M; BERACASSAT C; DAVIGNON J; GIRARD D; PELLETIER M; NAUDIN G; VINCENT J; FERRU J; ABITBOL JP; AVAKIAN A; BENEVISE B; CONNAN JB; DEVALMONT D; SAUTEREAU O; HERMAN D; LAUBY M; BALTUS C; GAILLARD JR; PLAN P; ROLLAND C; TAURILPIBRE EL; VIDAL M; GARCIN L; LIEB F; LIEBBAZILE C; AURIOL P; CAUSSE P; DADOLLE C; PARTRAT Y; PRIEUR T; VERGNON JM; ROS A; HANRION P; PLANEL P; BERAUD A; HOUPPERT Y; DUPONT B; FOUCHARD JL; MANTOVANI M; SILVAIN C; DEBIEUVRE D; CHANTELAT P; BLANCHON F; GRIGNET JP; ROYER E; AMAR P; BENSOUSSAN R; BISMUTH D; BRILLAUX F; DORFMANN M; DUCLOS G; FONTAINE M; GARCON G; GIRARD P; GUTH PC; KICHELEWSKI S; LEVY D; NEDELEC P; VASSEUR G; WALTER P; BEAUCE A; TRAN VT; LABESCAT J; COMPAN D; SCHEIMBERG A; MOURET G; DEPEUFEILHOUX A; MENZEL R
      CEFIXIM VERSUS AMOXICILLIN-CLAVULANATE IN THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC-BRONCHITIS, IN PATIENTS WITH RISK-FACTORS

      Medecine et maladies infectieuses
    48. CAMPEAU L; KNATTERUD GLMK; DOMANSKI M; HUNNINGHAKE DB; WHITE CW; GELLER NL; ROSENBERG Y; HERD A; COCANOUGHER MK; DUNN K; FARMER J; FOREYT J; GREGORY K; INSULL W; JACKSON M; KLEIMAN N; LEWIS R; LLOYD C; MARESH K; MATTHEW C; MINOR S; ROBERTS R; SALMON A; SHACKELFORD P; STEWART R; THOMPSON M; YOUNG J; GUINN A; HARRIS G; HEIBIG J; LEVY VV; FORRESTER J; HICKEY A; BUCHBINDER N; DAVIDSON R; DRURY K; EBER L; EIGLER N; GEFT I; GOLDBERG S; GRODAN P; HENDEL J; HIGGINS S; HODGSON T; HUGHES L; KARLSBERG R; KATZ J; LEPOR N; LITVAK F; LUPTAK Y; MADERA G; MARCUS H; MONDKAR A; NEIDORF B; NEUMANN M; NIVATPUMIN T; RABINOWITZ Y; RAYMOND M; READER A; RURYCZ V; SCHAPIRA J; SCHLANGER J; SILVERBERG R; SMITH A; TABAK S; VALOVIS R; GRAY R; HOOGWERF B; STEWART W; BAERVEDT G; BOTTSILVERMAN C; BREEN C; BUCKNER P; CABRAL J; CRESSMAN M; FONSECA C; FOSTER J; FOSTER R; GUTMAN F; HARRIS L; HEUPLER F; HOBBS R; HUANG S; KALENAK J; KASSEM M; KOSMORSKY G; KRAMER J; KURZAWA C; LANGSTON R; LINCOFF M; LINDBERG J; LOWDER C; MCCAFFERTY F; MCKEOWN D; MEISLER D; MENDLOVIC D; MEYERS S; MOORE J; NOUSEK J; RAYMOND R; RINCON G; ROBIN J; ROCKWOOD E; SHELDON W; SIMPFENDORFER C; WALSH H; WANESS A; WRIGHT K; YANAK F; GOULET C; BEDARD H; BOIS M; BUJOLD S; COTE G; DAVIGNON J; DEBELDER M; DUCHARME AM; DOUCET S; DUMAS J; DYDRA I; FOUCHER S; CREPEAU J; GOSSELIN G; GROULX D; JOYAL M; JUNEAU M; LESPERANCE J; LEVESQUE C; LEVESQUE J; MARCIL M; OLIVIER M; PASTERNAC A; POITRAS AM; POITRAS D; QUEVILLON A; RIOUX C; ROBITAILLE D; SISOUPHONE K; SOLYMOSS C; HUNNINGHAKE D; CHRISTIANSON B; DIANGELIS N; GARDNER K; HELGREN R; IACARELLA C; KNOBLOCH W; LAU L; LAXSON D; LEON A; LONDON E; MANION R; MCDONALD K; MCGINN A; MIANULLI M; ROBINSON J; TURNER G; WANG Y; WHITE C; WILSON R; ZIMMER S; GOBEL F; ANDERSON P; BAUMGARD C; CHRISTENSEN J; FULCO A; HANSON K; JOHNSON C; LARSON B; MADISON J; MCCORMACK P; OSTROV C; PECHA R; PEDERSON W; PIER T; RANDALL M; RODMAN W; ROELLER S; SCOTT K; SHER N; SPEILMAN J; THOMPSON R; ZUPFER S; GOLDENBERG I; HEALY B; KNATTERUD G; TERRIN M; CANNER M; FICK S; FORMAN S; HANSON D; HOWARD J; HUANG AL; KARABELAS S; LOPRESTI F; MERCER W; RA K; RANDALL A; SCHACTMAN M; SCHLEIGH B; SNIDER R; MIRENZI E; FISHER M; FOX NL; CZAJKOWSKI S; GELLER N; PROBSTFIELD J; SHUMAKER S; WITTES J; YUSUF S; ZUCKER D; CARTLAND J; DAS G; MEYER S; POWERS T; RINGDAL D; ROSZA Z; SHAHEEN B; SIREK M; STONE C; SNIDER J; VANYI J; ALAUPOVIC P; FESMIRE J; WALENGA J; BERMES E; HOPPENSTEADT D; PIFARRE R; CARLETON R; BAILEY K; BRODY B; CAIRNS J; FURBERG C; FUSTER V; GRONDIN C; JENKINS D; LAROSA J; MEIER P
      THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS

      The New England journal of medicine
    49. FREDENRICH A; GIROUX LM; TREMBLAY M; KRIMBOU L; DAVIGNON J; COHN JS
      PLASMA-LIPOPROTEIN DISTRIBUTION OF APOC-III IN NORMOLIPIDEMIC AND HYPERTRIGLYCERIDEMIC SUBJECTS - COMPARISON OF THE APOC-III TO APOE RATIO IN DIFFERENT LIPOPROTEIN FRACTIONS

      Journal of lipid research
    50. KRIMBOU L; TREMBLAY M; DAVIGNON J; COHN JS
      CHARACTERIZATION OF HUMAN PLASMA APOLIPOPROTEIN E-CONTAINING LIPOPROTEINS IN THE HIGH-DENSITY-LIPOPROTEIN SIZE RANGE - FOCUS ON PRE-BETA(1)-LPE, PRE-BETA(2)-LPE, AND ALPHA-LPE

      Journal of lipid research
    51. GREWAL T; CHAMBERLAND A; LEFEBVRE C; LAVIGNE J; BOUDREAU M; DAVIGNON J; MINNICH A
      INDUCTION OF STAT1-ALPHA IN SCAVENGER RECEPTOR OVEREXPRESSING MONOCYTES OF A NORMOLIPIDEMIC WITH PLANAR XANTHOMAS

      Atherosclerosis
    52. ROEDERER GO; MAILLOUX H; DAVIGNON J
      VARIABILITY IN THE RESPONSE TO ATORVASTATIN IN 2 SIBLINGS HOMOZYGOTE FOR THE SAME LDL-RECEPTOR GENE MUTATION

      Atherosclerosis
    53. GIROUX LM; FREDENRICH A; MARCOUX C; COHN JS; DAVIGNON J
      FURTHER CHARACTERIZATION OF TRIGLYCERIDE-RICH LIPOPROTEINS FROM PATIENTS AFFECTED WITH PSEUDO-TYPE-III DYSLIPOPROTEINEMIA

      Atherosclerosis
    54. DAVIGNON J
      THE PLEIOTROPIC EFFECTS OF DRUGS AFFECTING LIPID-METABOLISM

      Atherosclerosis
    55. MINNICH A; GREWAL T; BOUDREAU M; DAVIGNON J
      AN INHERITED ABNORMALITY IN MONOCYTE SR EXPRESSION IS ASSOCIATED WITHPLANAR XANTHOMAS

      Atherosclerosis
    56. COHN JS; DAVIGNON J
      DIFFERENT APPROACHES TO THE DETECTION AND QUANTIFICATION OF TRIGLYCERIDE-RICH LIPOPROTEIN REMNANTS

      Atherosclerosis
    57. KRIMBOU L; TREMBLAY M; JACQUES H; DAVIGNON J; COHN JS
      IN-VITRO FACTORS AFFECTING THE CONCENTRATION OF GAMMA-LPE (GAMMA-LPE)IN HUMAN PLASMA

      Atherosclerosis
    58. HEINONEN T; DAVILA M; DAVIGNON J; BLACK DM
      2-YEAR TREATMENT EXPERIENCE WITH HIGH-DOSE ATORVASTATIN

      Atherosclerosis
    59. PIOLOT A; BLACHE D; DAVIGNON J; LUSSIERCACAN S
      HETEROGENEOUS EFFECT OF N-3 POLYUNSATURATED FATTY-ACIDS (PUFAS) ON LDL IN-VITRO OXIDATION IN HEALTHY-SUBJECTS

      Atherosclerosis
    60. MARCOUX C; TREMBLAY M; JACQUES H; FREDENRICH A; NAKAJIMA K; DAVIGNON J; COHN JS
      PLASMA REMNANT-LIKE PARTICLE (RLP) LIPID AND APOLIPOPROTEIN LEVELS INNORMOLIPIDEMIC AND HYPERLIPIDEMIC SUBJECTS

      Atherosclerosis
    61. GENEST J; MARCIL M; YU L; BATAL R; KRIMBOU L; BOUCHER B; DAVIGNON J; ORAM JF; COHN JS
      FAMILIAL HDL DEFICIENCY - A CELLULAR CHOLESTEROL TRANSPORT DEFECT

      Atherosclerosis
    62. GIROUX LM; COHN JS; LAMARRE J; DAVIGNON J
      PSEUDO TYPE-III DYSLIPOPROTEINEMIA IS ASSOCIATED WITH NORMAL FIBROBLAST LIPOPROTEIN RECEPTOR ACTIVITY

      Atherosclerosis
    63. VOHL MC; MOORJANI S; ROY M; GAUDET D; TORRES AL; MINNICH A; GAGNE C; TREMBLAY G; LAMBERT M; BERGERON J; COUTURE P; PERRON P; BLAICHMAN S; BRUN LD; DAVIGNON J; LUPIEN PJ; DESPRES JP
      GEOGRAPHIC-DISTRIBUTION OF FRENCH-CANADIAN LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE-MUTATIONS IN THE PROVINCE OF QUEBEC

      Clinical genetics
    64. MARCOUX C; TREMBLAY M; JACQUES H; FREDENRICH A; NAKAJIMA K; DAVIGNON J; COHN JS
      PLASMA-CONCENTRATION OF REMNANT-LIKE LIPOPROTEIN APO-B, APOC-III AND APOE IN NORMOLIPIDEMIC AND HYPERLIPIDEMIC HUMAN-SUBJECTS

      Clinical chemistry
    65. MARCOUX C; LUSSIERCACAN S; DAVIGNON J; COHN JS
      ASSOCIATION OF LP(A) RATHER THAN INTEGRALLY-BOUND APO(A) WITH TRIGLYCERIDE-RICH LIPOPROTEINS OF HUMAN-SUBJECTS

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    66. CARMENA R; LUSSIERCACAN S; ROY M; MINNICH A; LINGENHEL A; KRONENBERG F; DAVIGNON J
      LP(A) LEVELS AND ATHEROSCLEROTIC VASCULAR-DISEASE IN A SAMPLE OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA SHARING THE SAME GENE DEFECT

      Arteriosclerosis, thrombosis, and vascular biology
    67. COHN JS; TREMBLAY M; AMIOT M; BOUTHILLIER D; ROY M; GENEST J; DAVIGNON J
      PLASMA-CONCENTRATION OF APOLIPOPROTEIN-E IN INTERMEDIATE-SIZED REMNANT-LIKE LIPOPROTEINS IN NORMOLIPIDEMIC AND HYPERLIPIDEMIC SUBJECTS

      Arteriosclerosis, thrombosis, and vascular biology
    68. DAVIGNON J
      A LIPID CLINIC ASSOCIATED WITH A RESEARCH LABORATORY WORKING ON DYSLIPOPROTEINEMIAS AND ATHEROSCLEROSIS

      Canadian journal of cardiology
    69. BAKKERARKEMA RG; DAVIDSON MH; GOLDSTEIN RJ; DAVIGNON J; ISAACSOHN JL; WEISS SR; KEILSON LM; BROWN WV; MILLER VT; SHURZINSKE LJ; BLACK DM
      EFFICACY AND SAFETY OF A NEW HMG-COA REDUCTASE INHIBITOR, ATORVASTATIN, IN PATIENTS WITH HYPERTRIGLYCERIDEMIA

      JAMA, the journal of the American Medical Association
    70. FARLOW MR; LAHIRI D; HUI S; DAVIGNON J; POIRIER J
      APOLIPOPROTEIN-E GENOTYPE PREDICTS RESPONSE TO TACRINE IN ALZHEIMERS-DISEASE

      Neurology
    71. GUILLAUME D; BERTRAND P; DEA D; DAVIGNON J; POIRIER J
      APOLIPOPROTEIN-E AND LOW-DENSITY-LIPOPROTEIN BINDING AND INTERNALIZATION IN PRIMARY CULTURES OF RAT ASTROCYTES - ISOFORM-SPECIFIC ALTERATIONS

      Journal of neurochemistry
    72. GIRY C; GIROUX LM; ROY M; DAVIGNON J; MINNICH A
      CHARACTERIZATION OF INHERITED SCAVENGER RECEPTOR OVEREXPRESSION AND ABNORMAL MACROPHAGE PHENOTYPE IN A NORMOLIPIDEMIC SUBJECT WITH PLANAR XANTHOMAS

      Journal of lipid research
    73. MARCIL M; BOUCHER B; GAGNE E; DAVIGNON J; HAYDEN M; GENEST J
      LACK OF ASSOCIATION OF THE APOLIPOPROTEIN A-I-C-III-A-IV GENE XMNI AND SSTI POLYMORPHISMS AND OF THE LIPOPROTEIN-LIPASE GENE-MUTATIONS IN FAMILIAR COMBINED HYPERLIPOPROTEINEMIA IN FRENCH-CANADIAN SUBJECTS

      Journal of lipid research
    74. DAVIGNON J; COHN JS
      TRIGLYCERIDES - A RISK FACTOR FOR CORONARY HEART-DISEASE

      Atherosclerosis
    75. JACOTOT B; BETTERIDGE J; ASSMANN G; CASTELLI W; DAVIGNON J; TURPIN G; BERTHEZENE F; SCHAEFFER; YOMTOV; POMMETTA
      ROUND-TABLE DISCUSSION - PRACTICAL ISSUES IN THE MANAGEMENT OF DYSLIPIDEMIC PATIENTS

      Atherosclerosis
    76. BETARD C; KESSLING AM; ROY M; DAVIGNON J
      INFLUENCE OF GENETIC-VARIABILITY IN THE NONDELETION LDL-RECEPTOR ALLELE ON PHENOTYPIC VARIATION IN FRENCH-CANADIAN FAMILIAL HYPERCHOLESTEROLEMIA HETEROZYGOTES SHARING A NULL LDL-RECEPTOR GENE DEFECT

      Atherosclerosis
    77. ROBITAILLE N; CORMIER G; COUTURE R; BOUTHILLIER D; DAVIGNON J; PERUSSE L
      APOLIPOPROTEIN-E POLYMORPHISM IN A FRENCH-CANADIAN POPULATION OF NORTHEASTERN QUEBEC - ALLELE FREQUENCIES AND EFFECTS ON BLOOD LIPID AND LIPOPROTEIN LEVELS

      Human biology
    78. DURAND P; FORTIN LJ; LUSSIERCACAN S; DAVIGNON J; BLACHE D
      HYPERHOMOCYSTEINEMIA INDUCED BY FOLIC-ACID DEFICIENCY AND METHIONINE LOAD - APPLICATIONS OF A MODIFIED HPLC METHOD

      Clinica chimica acta
    79. LUSSIERCACAN S; XHIGNESSE M; PIOLOT A; SELHUB J; DAVIGNON J; GENEST J
      PLASMA TOTAL HOMOCYSTEINE IN HEALTHY-SUBJECTS - SEX-SPECIFIC RELATIONWITH BIOLOGICAL TRAITS

      The American journal of clinical nutrition
    80. MARCIL M; BOUCHER B; KRIMBOU L; SOLYMOSS BC; DAVIGNON J; FROHLICH J; GENEST J
      SEVERE FAMILIAL HDL DEFICIENCY IN FRENCH-CANADIAN KINDREDS - CLINICAL, BIOCHEMICAL, AND MOLECULAR CHARACTERIZATION

      Arteriosclerosis, thrombosis, and vascular biology
    81. CAMPOS H; ROEDERER GO; LUSSIERCACAN S; DAVIGNON J; KRAUSS RM
      PREDOMINANCE OF LARGE LDL AND REDUCED HDL(2) CHOLESTEROL IN NORMOLIPIDEMIC MEN WITH CORONARY-ARTERY DISEASE

      Arteriosclerosis, thrombosis, and vascular biology
    82. MINNICH A; DELANGAVANT G; LAVIGNE J; ROEDERER G; LUSSIERCACAN S; DAVIGNON J
      G-]A SUBSTITUTION AT POSITION-75 OF THE APOLIPOPROTEIN-A-I GENE PROMOTER - EVIDENCE AGAINST A DIRECT EFFECT ON HDL CHOLESTEROL LEVELS

      Arteriosclerosis, thrombosis, and vascular biology
    83. MCNICOLL S; LATOUR Y; RONDEAU C; BOUTHILLIER D; DAVIGNON J; GENEST J
      CARDIOVASCULAR RISK-FACTORS AND LIPOPROTEIN PROFILE IN FRENCH-CANADIANS WITH PREMATURE CAD - IMPACT OF THE NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM-II

      Canadian journal of cardiology
    84. POIRIER J; MINNICH A; DAVIGNON J
      APOLIPOPROTEIN-E, SYNAPTIC PLASTICITY AND ALZHEIMERS-DISEASE

      Annals of medicine
    85. SASS C; GIROUX LM; MA YH; ROY M; LAVIGNE J; LUSSIERCACAN S; DAVIGNON J; MINNICH A
      EVIDENCE FOR A CHOLESTEROL-LOWERING GENE IN A FRENCH-CANADIAN KINDREDWITH FAMILIAL HYPERCHOLESTEROLEMIA

      Human genetics
    86. DAVIGNON J
      PROSPECTS FOR DRUG-THERAPY FOR HYPERLIPOP ROTEINEMIA

      Diabete et metabolisme
    87. HAVILAND MB; LUSSIERCACAN S; DAVIGNON J; SING CF
      IMPACT OF APOLIPOPROTEIN-E GENOTYPE VARIATION ON MEANS, VARIANCES, AND CORRELATIONS OF PLASMA-LIPID, LIPOPROTEIN, AND APOLIPOPROTEIN TRAITSIN OCTOGENARIANS

      American journal of medical genetics
    88. MINNICH A; WEISGRABER KH; NEWHOUSE Y; DONG LM; FORTIN LJ; TREMBLAY M; DAVIGNON J
      IDENTIFICATION AND CHARACTERIZATION OF A NOVEL APOLIPOPROTEIN-E VARIANT, APOLIPOPROTEIN-E3' (ARG(136)-]HIS) - ASSOCIATION WITH MILD DYSLIPIDEMIA AND DOUBLE PRE-BETA VERY-LOW-DENSITY LIPOPROTEINS

      Journal of lipid research
    89. MINNICH A; KESSLING A; ROY M; GIRY C; DELANGAVANT G; LAVIGNE J; LUSSIERCACAN S; DAVIGNON J
      PREVALENCE OF ALLELES ENCODING DEFECTIVE LIPOPROTEIN-LIPASE IN HYPERTRIGLYCERIDEMIC PATIENTS OF FRENCH-CANADIAN DESCENT

      Journal of lipid research
    90. RADER DJ; MANN WA; CAIN W; KRAFT HG; USHER D; ZECH LA; HOEG JM; DAVIGNON J; LUPIEN P; GROSSMAN M; WILSON JM; BREWER HB
      THE LOW-DENSITY-LIPOPROTEIN RECEPTOR IS NOT REQUIRED FOR NORMAL CATABOLISM OF LP(A) IN HUMANS

      The Journal of clinical investigation
    91. SASS C; GIROUX LM; LUSSIERCACAN S; DAVIGNON J; MINNICH A
      UNEXPECTED CONSEQUENCES OF DELETION OF THE FIRST 2 REPEATS OF THE LIGAND-BINDING DOMAIN FROM THE LOW-DENSITY-LIPOPROTEIN RECEPTOR - EVIDENCE FROM A HUMAN MUTATION

      The Journal of biological chemistry
    92. MERCURE C; THIBAULT G; LUSSIERCACAN S; DAVIGNON J; SCHIFFRIN EL; REUDELHUBER TL
      MOLECULAR ANALYSIS OF HUMAN PRORENIN PROSEGMENT VARIANTS IN-VITRO ANDIN-VIVO

      The Journal of biological chemistry
    93. LANSBERG PJ; MITCHEL YB; SHAPIRO D; KASTELEIN JJP; ALTMAN R; JERUMS G; BOLZANO K; GIANNINI S; DAVIGNON J; DEWAILLY P; DARIOLI R; MANCINI M; SCOTT R; HAYDEN MR
      LONG-TERM EFFICACY AND TOLERABILITY OF SIMVASTATIN IN A LARGE COHORT OF ELDERLY HYPERCHOLESTEROLEMIC PATIENTS

      Atherosclerosis
    94. BLACHE D; RODRIGUEZ C; DAVIGNON J
      ENHANCED SUSCEPTIBILITY OF CHOLESTERYL SULFATE-ENRICHED LOW-DENSITY LIPOPROTEINS TO COPPER-MEDIATED OXIDATION

      FEBS letters
    95. BLACHE D; RODRIGUEZ C; DAVIGNON J
      PROOXIDANT EFFECTS OF 7-HYDROPEROXYCHOLEST-5-EN-3-BETA-OL ON THE COPPER-INITIATED OXIDATION OF LOW-DENSITY-LIPOPROTEIN

      FEBS letters
    96. ROY M; SING CF; BETARD C; DAVIGNON J
      IMPACT OF A COMMON MUTATION OF THE LDL RECEPTOR GENE, IN FRENCH-CANADIAN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, ON MEANS, VARIANCES AND CORRELATIONS AMONG TRAITS OF LIPID-METABOLISM

      Clinical genetics
    97. MINNICH A; ROY M; CHAMBERLAND A; LAVIGNE J; DAVIGNON J
      NEW METHODS FOR RAPID DETECTION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR AND APOLIPOPROTEIN-B GENE-MUTATIONS CAUSING FAMILIAL HYPERCHOLESTEROLEMIA

      Clinical biochemistry
    98. WESOLOWSKA E; MARCIL M; LUSSIERCACAN L; LATOUR Y; DAVIGNON J; GENEST J
      ANGIOTENSIN-CONVERTING ENZYME (ACE) GENOTYPES IN FRENCH-CANADIAN SUBJECTS WITH PREMATURE CORONARY-ARTERY DISEASE

      Circulation
    99. GIRY C; DAVIGNON J; MINNICH A
      DIFFERENTIAL EXPRESSION AND STABILITY OF SCAVENGER RECEPTOR ISOFORM MESSENGER-RNA DURING MATURATION OF HUMAN MONOCYTES

      Circulation
    100. MINNICH A; LUSSIERCACAN S; SASS C; ROY M; DAVIGNON J
      ALLELE-SPECIFIC EXPRESSION OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 15:31:38